A5072497975- Long-Term Effects of COVID-19
- COVID-19 Clinical Research Studies
- Kidney Stones and Urolithiasis Treatments
- Autoimmune and Inflammatory Disorders Research
- Respiratory Support and Mechanisms
- Kawasaki Disease and Coronary Complications
- Urological Disorders and Treatments
- Pediatric Urology and Nephrology Studies
- Systemic Lupus Erythematosus Research
- Sarcoidosis and Beryllium Toxicity Research
- Thermal Regulation in Medicine
- Aortic aneurysm repair treatments
- COVID-19 Impact on Reproduction
- Acute Lymphoblastic Leukemia research
- Sepsis Diagnosis and Treatment
- Stress Responses and Cortisol
Hospital Universitario de Burgos
2016-2021
Universidad de Burgos
2020
Objectives. To assess the influence of corticosteroid pulses on 60-day mortality in hospitalized patients with severe COVID-19. Methods. We designed a multicenter retrospective cohort study three teaching hospitals Castilla y León, Spain (865,096 people). selected confirmed COVID-19 and lung involvement pO2/FiO2<300, excluding those exposed to immunosuppressors before or during hospitalization, terminally ill at admission, who died first 24 hours. performed propensity score matching (PSM)...
ABSTRACT Background: COVID-19 has high mortality in hospitalized patients, and we need effective treatments. Our objective was to assess corticosteroid pulses’ influence on 60-days patients with severe COVID-19, intensive care admission, hospital stay. Methods: We designed a multicenter retrospective cohort study three teaching hospitals of Castilla y León, Spain (865.096 people). selected confirmed lung involvement pO2/FiO2 < 300, excluding those exposed immunosuppressors before or...
Background: COVID-19 has high mortality in hospitalized patients, and we need effective treatments. Our objective was to assess corticosteroid pulses' influence on 60-days patients with severe COVID-19, intensive care admission, hospital stay. Methods: We designed a multicenter retrospective cohort study three teaching hospitals of Castilla y León, Spain (865.096 people). selected confirmed lung involvement pO2 /FiO2 < 300, excluding those exposed immunosuppressors before or during...